Sickle Cell Disease Trial, Recruiting NCT06367192 Sponsor: St. Jude Children's Research Hospital Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT06367192
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child has been diagnosed with sickle cell disease (any type/form of the condition)
  • The child is already enrolled in a specific hospital program called the Sickle Cell Clinical Research Intervention Program (SCCRIP)
  • The child is between 3.5 and 6.5 years old at the time of joining the trial
  • English is the main language spoken at home
  • Both the child and at least one parent are willing to take part and give their agreement to participate
  • For caregiver participants: you are the parent or caregiver of a child aged 3.5–6.5 years who has sickle cell disease and is enrolled in SCCRIP

Who may not be able to join:

  • Caregivers who do not have a child aged 3.5–6.5 years with sickle cell disease who is enrolled in SCCRIP
  • People whose main language is not English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: ANDREW Heitzer, PhD, St. Jude Children's Research Hospital

Phone: 888-226-4343

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
St. Jude Children's Research Hospital
Registry
ClinicalTrials.gov
Start date
31 March 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Intervention Measure; Acceptability of Intervention Measure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov